Loading...
tPA as a therapeutic target in stroke
BACKGROUND: Ischemic stroke is a leading cause of morbidity and mortality worldwide and recombinant human tissue-type Plasminogen Activator (tPA) is the prominent among very few therapeutics used in its treatment. Due to complications attributed to the drug, most notably transformation of ischemia t...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3824365/ https://ncbi.nlm.nih.gov/pubmed/18208365 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728222.12.2.159 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|